CV Benefit of Eicosapentaenoic Acid Seen at All eGFR Levels CV Benefit of Eicosapentaenoic Acid Seen at All eGFR Levels

Daily icosapent ethyl safely reduced fatal and nonfatal ischemic events in patients with reduced kidney function in an extension of the REDUCE-IT trial.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Nephrology News Source Type: news